{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:10:52Z","timestamp":1760775052173,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.bmcl.2019.04.005","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T12:10:50Z","timestamp":1554379850000},"page":"1291-1297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Design, synthesis, and biological evaluation of novel 2\u2032-deoxy-2\u2032-fluoro-2\u2032-C-methyl 8-azanebularine derivatives as potent anti-HBV agents"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7746-6640","authenticated-orcid":false,"given":"Wu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youmei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanjun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3711-0006","authenticated-orcid":false,"given":"Wenquan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yubing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingduan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junbiao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.04.005_b0005","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/s41467-017-01953-y","article-title":"Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques","volume":"8","author":"Burwitz","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmcl.2019.04.005_b0010","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41598-018-19184-6","article-title":"Correlations between mitochondrial DNA haplogroup D5 and chronic hepatitis B virus infection in Yunnan, China","volume":"8","author":"Li","year":"2018","journal-title":"Sci Rep UK"},{"key":"10.1016\/j.bmcl.2019.04.005_b0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tim.2017.07.006","article-title":"Mechanisms of hepatitis B virus persistence","volume":"26","author":"Tsai","year":"2018","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bmcl.2019.04.005_b0020","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s11095-010-0112-z","article-title":"Drug delivery systems and liver targeting for improved pharmacotherapy of the hepatitis B virus (HBV) infection","volume":"27","author":"Cuestas","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.bmcl.2019.04.005_b0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2017.08.020","article-title":"Tenofovir alafenamide as a rescue therapy in a patient with HBV-cirrhosis with a history of Fanconi syndrome and multidrug resistance","volume":"68","author":"Grossi","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.bmcl.2019.04.005_b0030","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.tet.2017.12.034","article-title":"A new scalable synthesis of entecavir","volume":"74","author":"Gioti","year":"2018","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2019.04.005_b0035","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/med.21490","article-title":"2'-Fluoro-6'-methylene carbocyclic adenosine and its phosphoramidate prodrug: a novel anti-HBV agent, active against drug-resistant HBVmutants","volume":"38","author":"Singh","year":"2018","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmcl.2019.04.005_b0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-2005-915647","article-title":"Current treatment of chronic hepatitis B: benefits and limitations","volume":"25","author":"Perrillo","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.bmcl.2019.04.005_b0045","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1093\/cid\/cix1131","article-title":"Dolutegravir plus lamivudine maintain HIV-1 suppression through week 48 in a pilot randomized trial","volume":"66","author":"Taiwo","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2019.04.005_b0050","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/cid\/cix734","volume":"65","author":"Pulido","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmcl.2019.04.005_b0055","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.1021\/cr9001462","article-title":"Cu(I)-Catalyzed huisgen azide-alkyne 1,3-dipolar cycloaddition reaction in nucleoside, nucleotide, and oligonucleotide chemistry","volume":"109","author":"Amblard","year":"2009","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2019.04.005_b0060","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/j.tetlet.2018.04.003","article-title":"Solvent- and environment-dependent fluorescence of modified nucleobases","volume":"59","author":"Seio","year":"2018","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmcl.2019.04.005_b0065","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.bmc.2008.11.057","article-title":"Interrogating the mechanism of a tight binding inhibitor of AIR carboxylase","volume":"17","author":"Firestine","year":"2009","journal-title":"Bioorgan Med Chem"},{"key":"10.1016\/j.bmcl.2019.04.005_b0070","doi-asserted-by":"crossref","first-page":"6729","DOI":"10.1021\/cr9002165","article-title":"C-nucleosides: synthetic strategies and biological applications","volume":"109","author":"\u0160tambask\u00fd","year":"2009","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2019.04.005_b0075","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bmcl.2017.11.029","article-title":"Isosteric ribavirin analogues: synthesis and antiviral activities","volume":"28","author":"Zhurilo","year":"2018","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.04.005_b0080","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1021\/acs.joc.6b00323","article-title":"Functionalization of 2H\u20131,2,3-triazole C-nucleoside template via N2 selective arylation","volume":"81","author":"Lopes","year":"2016","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2019.04.005_b0085","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1055\/s-0036-1588409","article-title":"Synthesis of C-ribosyl-1,2,3-triazolyl carboxamides","volume":"49","author":"Solarte","year":"2017","journal-title":"Synthesis"},{"key":"10.1016\/j.bmcl.2019.04.005_b0090","doi-asserted-by":"crossref","first-page":"13484","DOI":"10.1021\/acs.chemrev.5b00545","article-title":"Nucleosides with transposed base or 4'-hydroxymethyl moieties and their corresponding oligonucleotides","volume":"115","author":"Toti","year":"2015","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2019.04.005_b0095","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1021\/jm101286g","article-title":"Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors","volume":"54","author":"Gillerman","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.04.005_b0100","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1039\/b908017a","article-title":"8-Aza-2'-deoxyguanosine: base pairing, mismatch discrimination and nucleobase anion fluorescence sensing in single-stranded and duplex DNA","volume":"7","author":"Seela","year":"2009","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2019.04.005_b0105","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.antiviral.2012.10.003","article-title":"Anti-hepatitis B virus activities of a-DDB-FNC, a novel nucleoside-biphenyld-icarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice","volume":"96","author":"Yang","year":"2012","journal-title":"Antivir Res"},{"key":"10.1016\/j.bmcl.2019.04.005_b0110","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1021\/jm5012963","article-title":"Synthesis and biological evaluation of 4-substituted fluoronucleoside analogs for the treatment of hepatitis B virusinfection","volume":"58","author":"Yang","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.04.005_b0115","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1016\/j.ejmech.2011.06.020","article-title":"Synthesis of new 2'-deoxy-2'-fluoro-4'-azido nucleoside analogues as potentanti-HIV agents","volume":"46","author":"Wang","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.04.005_b0120","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1016\/j.bmcl.2010.05.090","article-title":"Synthesis and anti-HIV activity of 2'-deoxy-2'-fluoro-4'-C-ethynyl nucleoside","volume":"20","author":"Wang","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2019.04.005_b0125","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejmech.2015.06.030","article-title":"Design, synthesis, and biological evaluation of new N4-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents","volume":"101","author":"Lv","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.04.005_b0130","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1254\/jphs.13230FP","article-title":"Anti-hepatitis B virus activity of a-DDB-FNCG, a novel nucleoside-biphenyldicarboxylate compound in vitro and in vivo","volume":"126","author":"Yang","year":"2014","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bmcl.2019.04.005_b0135","doi-asserted-by":"crossref","first-page":"679","DOI":"10.3851\/IMP2094","article-title":"Antiviral activity of FNC, 2\u2032-deoxy-2\u2032-\u03b2- fluoro-4\u2032-azidocytidine, against human and duck HBV replication","volume":"17","author":"Zheng","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.bmcl.2019.04.005_b0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/15257770.2013.797994","article-title":"A new route for the synthesis of the 4- amino-5-fluoro-7-(2'-deoxy-2'-fluoro-2'-C-methyl\u2013d-ribofuranosyl)-1H-pyrrolo[2,3-d]pyrimidine","volume":"32","author":"Hu","year":"2013","journal-title":"Nucleos Nucleot Nucl"},{"key":"10.1016\/j.bmcl.2019.04.005_b0145","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/acs.jmedchem.5b01807","article-title":"Discovery of an orally active and liver-targeted prodrug of 5-fluoro-2'-deoxyuridine for the treatment of hepatocellular carcinoma","volume":"59","author":"Peng","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.04.005_b0150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ejmech.2017.11.028","article-title":"Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro-4'-azido nucleoside derivatives as potent anti-HBV agents","volume":"143","author":"Liu","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.04.005_b0155","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1039\/C6OB02121B","article-title":"The first example of palladium-catalyzed cascade amidine arylation-intramolecular ester amidation for the synthesis of hypoxanthines: application to the synthesis of 8-azanebularine analogues","volume":"15","author":"Yang","year":"2017","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2019.04.005_b0160","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.1021\/jm100863x","article-title":"Discovery of a \u03b2-d-2\u2019-Deoxy-2\u2019-a-fluoro-2\u2019-\u03b2- C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus","volume":"53","author":"Sofia","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.04.005_b0165","doi-asserted-by":"crossref","first-page":"11744","DOI":"10.1016\/j.tet.2005.09.034","article-title":"Efficient Pd(0)-catalyzed synthesis of 1,2,3-triazolo-3'-deoxycarbanucleosides and their analogues","volume":"61","author":"Joubert","year":"2005","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmcl.2019.04.005_b0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2012.02.030","article-title":"In vitro activity of cepharanthine hydrochloride against clinical wild-type and lamivudine-resistant hepatitis B virus isolates","volume":"683","author":"Zhou","year":"2012","journal-title":"Eur J Pharmacol"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19302148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19302148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:29:27Z","timestamp":1760772567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19302148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":34,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0960894X19302148"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.04.005","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of novel 2\u2032-deoxy-2\u2032-fluoro-2\u2032-C-methyl 8-azanebularine derivatives as potent anti-HBV agents","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}